Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-02-01
DOI
https://doi.org/10.1136/jitc-2024-009352
Citations
5
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
5.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Carsten Weishaupt, Patrick Terheyden, Beate Schmitt-Bormann, Erika Richtig et al.
5 citations
Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and Biomarkers
5.23
article

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Carsten Weishaupt, Patrick Terheyden, Beate Schmitt-Bormann, Erika Richtig, Peter Brossart, Casilda Llácer Pérez, Ioannis Thomas, Célèste Lebbé, Sebastian Ochsenreither, Lucie Heinzerling, Sven D. Koch, Marina Sekacheva, Jürgen Krauß, Paula Codó, Ulrike Gnad-Vogt, Thomas Eigentler, Yulia Semiletova, Juan Martín-Liberal, Gianluca Quintini, Игорь Вячеславович Самойленко, A. Oberoi, Marina González, Michael Fluck, Peter Wengenmayer, Martin Falk, Ainara Soria, Tobias Seibel, Oliver Schönborn‐Kellenberger, Lukas Koch, Artem Poltoratskiy, Caroline Robert, Jana Heß, Michael Erdmann, Peter Mohr, Franz Bauernfeind
article en
5 citations

Abstract

No abstract available for this paper.
Journal for ImmunoTherapy of CancerVol. 13(2)
Institut Català d'Ornitologia (ES), Inserm (FR), St Petersburg University (RU), Medical University of Graz (AT), Université Paris Cité (FR), Université Paris-Saclay (FR), University Hospital Bonn (DE), Institut Gustave Roussy (FR), LMU Klinikum (DE), Humboldt-Universität zu Berlin (DE), Universitätsklinikum Erlangen (DE), Russian Cancer Research Center NN Blokhin (RU), Sorbonne Paris Cité (FR), Assistance Publique – Hôpitaux de Paris (FR), University Hospital Münster (DE), Institut Català d'Oncologia (ES), National Center for Tumor Diseases (DE), Institute of Oncology NN Petrov (RU), Ministry of Health of the Russian Federation (RU), CureVac (Germany) (DE), Vall d'Hebron Hospital Universitari (ES), Elbe Kliniken Stade-Buxtehude (DE), Hôpital Saint-Louis (FR), Comprehensive Cancer Center Erlangen (DE), Fachklinik Hornheide (DE), Hospital Universitario Ramón y Cajal (ES), Instituto de Investigación Biomédica de Málaga (ES), Vall d'Hebron Institute of Oncology (ES), Bayer (Germany) (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE)
Amgen, Bristol-Myers Squibb, AstraZeneca, Sanofi, Regeneron Pharmaceuticals, Les Laboratories Pierre Fabre, Incyte
Good health and well-being
Openalex Percentile: Top 5%
Cancer Immunotherapy and Biomarkers
5.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.